Quality Assurance Associate II - Night Shift
TLDR
Oversee GMP manufacturing and cryopreservation operations, conducting Quality on the Floor activities, inspections, and real-time documentation review.
Capricor Therapeutics (NASDAQ: CAPR) is a biotechnology company dedicated to advancing transformative cell and exosome-based therapies for rare diseases. At the forefront of our innovation is Deramiocel (CAP-1002), our lead cell therapy in late-stage development for Duchenne muscular dystrophy. We are also harnessing our proprietary StealthX™ exosome platform to unlock new possibilities in targeted delivery and vaccinology. Every program reflects our commitment to pushing the boundaries of science and delivering life-changing treatments to patients and families who need them most.
Position Summary
This is an overnight (graveyard) shift role supporting off-hours GMP manufacturing. As a Quality Assurance Associate II at Capricor, you will serve as the primary Quality representative during overnight manufacturing operations (Graveyard Shift). In this role, you will provide Quality Assurance oversight for manufacturing, cryopreservation, and support activities while ensuring compliance with cGMP regulations, internal procedures, and quality standards. The ideal candidate brings experience in GMP-regulated environments, strong attention to detail, and the ability to make sound quality decisions independently during off-shift operations.
Key Responsibilities
Required Qualifications
Core Competencies
Shift Expectations, Work Environment & Physical Requirements
Work Environment & Physical Requirements
Shift Expectations
Why Capricor?
Capricor Therapeutics is advancing cell and exosome-based therapies with a focus on serious diseases where patients and families need new treatment options. Our work is grounded in scientific rigor, collaboration, and a shared commitment to moving meaningful therapies forward. Joining Capricor means being part of a mission-driven team working at the intersection of innovation, execution, and patient impact.
Come Work With Us
At Capricor, you’ll join a collaborative environment where employees are encouraged to contribute, grow, and help build the systems, science, and operations needed to support our next stage of growth. We value people who are thoughtful, accountable, hands-on, and motivated by work that can make a real difference.
Recruiting Fraud Notice
Capricor does not use Skype for interviews or recruiting activities. Candidates will only be contacted by someone using an official Capricor email address ending in @capricor.com. Capricor will never ask candidates to send money, deposit a check, purchase equipment, or provide payment for any reason as part of the recruiting or onboarding process.
Notice to Recruiting Agencies
Capricor Therapeutics does not accept candidate submissions or referrals from recruiting agencies, staffing firms, or third-party recruiters without express written approval from Talent Acquisition and a fully executed agreement with Capricor. Agencies that contact hiring managers directly, solicit business, or submit candidates without prior approval will not be considered for engagement. Any unsolicited submissions will become the property of Capricor Therapeutics, and no fees will be paid for candidates hired as a result of such submissions. We appreciate your cooperation and respect for this policy.
Benefits
Equity Compensation
Long-term equity incentive awards in accordance with company policy
Flexible Work Hours
When weekend or additional hours are worked, the manager will adjust the employee’s upcoming schedule as operationally appropriate to provide time off and help offset the additional hours.
Health Insurance
Company-paid basic life and AD&D insurance
Other voluntary benefits and wellness programs
Additional voluntary benefits and wellness programs may also be available.
Paid Parental Leave
Paid Time Off
Paid time off and company holidays
Capricor Therapeutics is a biotechnology company developing transformative cell and exosome-based therapies aimed at addressing rare diseases. Their lead product, Deramiocel (CAP-1002), is in late-stage development for Duchenne muscular dystrophy, while their proprietary StealthX™ exosome platform explores innovative solutions in targeted delivery and vaccinology.
- Founded
- Founded 2005
- Employees
- 201-500 employees
- Industry
- biotechnology
- Funding stage
- Public
- Stock ticker
- Publicly traded (CAPR)
- Total raised
- $330M raised
- Last funding
- Raised December 2025